 Jason Burdick
Concepts (744)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 137 | 2025 | 629 | 28.070 |
Why?
| | Hyaluronic Acid | 76 | 2025 | 214 | 15.590 |
Why?
| | Tissue Engineering | 82 | 2025 | 388 | 14.060 |
Why?
| | Biocompatible Materials | 82 | 2025 | 388 | 13.980 |
Why?
| | Polymers | 43 | 2025 | 477 | 7.200 |
Why?
| | Tissue Scaffolds | 39 | 2025 | 201 | 7.020 |
Why?
| | Bioprinting | 12 | 2025 | 24 | 6.960 |
Why?
| | Printing, Three-Dimensional | 18 | 2025 | 88 | 5.480 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 18 | 2017 | 70 | 4.960 |
Why?
| | Chondrogenesis | 24 | 2024 | 82 | 4.950 |
Why?
| | Extracellular Matrix | 31 | 2025 | 502 | 4.530 |
Why?
| | Myocardial Infarction | 34 | 2023 | 1021 | 3.710 |
Why?
| | Cartilage | 15 | 2024 | 181 | 3.210 |
Why?
| | Materials Testing | 24 | 2025 | 343 | 2.970 |
Why?
| | Cross-Linking Reagents | 23 | 2025 | 205 | 2.800 |
Why?
| | Ventricular Remodeling | 20 | 2023 | 255 | 2.690 |
Why?
| | Delayed-Action Preparations | 13 | 2018 | 172 | 2.640 |
Why?
| | Myocardium | 20 | 2023 | 978 | 2.620 |
Why?
| | Biomimetic Materials | 7 | 2024 | 69 | 2.590 |
Why?
| | Nanotubes | 9 | 2016 | 43 | 2.440 |
Why?
| | Drug Carriers | 9 | 2018 | 119 | 2.380 |
Why?
| | Cell Culture Techniques | 14 | 2024 | 336 | 2.370 |
Why?
| | Mechanotransduction, Cellular | 11 | 2023 | 111 | 2.360 |
Why?
| | Animals | 157 | 2025 | 35307 | 2.340 |
Why?
| | Nanofibers | 8 | 2021 | 20 | 2.260 |
Why?
| | Light | 14 | 2018 | 359 | 2.120 |
Why?
| | Stem Cells | 15 | 2020 | 574 | 2.110 |
Why?
| | Chondrocytes | 11 | 2021 | 203 | 1.960 |
Why?
| | Cartilage, Articular | 9 | 2021 | 292 | 1.930 |
Why?
| | Drug Delivery Systems | 16 | 2021 | 333 | 1.860 |
Why?
| | Cell Adhesion | 22 | 2022 | 452 | 1.860 |
Why?
| | Injections | 21 | 2023 | 174 | 1.800 |
Why?
| | Spheroids, Cellular | 6 | 2025 | 77 | 1.680 |
Why?
| | Cell Movement | 14 | 2024 | 944 | 1.680 |
Why?
| | Regeneration | 10 | 2019 | 181 | 1.650 |
Why?
| | Meniscus | 3 | 2023 | 21 | 1.590 |
Why?
| | Osteogenesis | 7 | 2021 | 172 | 1.560 |
Why?
| | beta-Cyclodextrins | 7 | 2019 | 27 | 1.520 |
Why?
| | Adhesives | 3 | 2022 | 13 | 1.470 |
Why?
| | Cadherins | 4 | 2018 | 188 | 1.470 |
Why?
| | Hepatic Stellate Cells | 3 | 2016 | 12 | 1.450 |
Why?
| | Cells, Cultured | 37 | 2023 | 4076 | 1.410 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 591 | 1.410 |
Why?
| | Cell Differentiation | 20 | 2023 | 1887 | 1.370 |
Why?
| | Absorbable Implants | 8 | 2015 | 35 | 1.370 |
Why?
| | Microspheres | 12 | 2014 | 124 | 1.360 |
Why?
| | Stem Cell Transplantation | 5 | 2018 | 164 | 1.360 |
Why?
| | Polyethylene Glycols | 19 | 2024 | 587 | 1.340 |
Why?
| | Combinatorial Chemistry Techniques | 4 | 2018 | 16 | 1.320 |
Why?
| | Mechanical Phenomena | 8 | 2018 | 83 | 1.320 |
Why?
| | Cellular Microenvironment | 6 | 2022 | 81 | 1.260 |
Why?
| | Swine | 20 | 2024 | 760 | 1.250 |
Why?
| | Antigens, CD | 3 | 2018 | 489 | 1.240 |
Why?
| | Glycerol | 4 | 2016 | 91 | 1.210 |
Why?
| | Peptides | 7 | 2018 | 923 | 1.180 |
Why?
| | Ventricular Function, Left | 14 | 2023 | 527 | 1.160 |
Why?
| | Biomedical Technology | 3 | 2020 | 41 | 1.160 |
Why?
| | Elastomers | 5 | 2016 | 25 | 1.150 |
Why?
| | Cell Lineage | 4 | 2021 | 332 | 1.140 |
Why?
| | Rheology | 11 | 2022 | 90 | 1.120 |
Why?
| | Osteoblasts | 7 | 2008 | 116 | 1.120 |
Why?
| | Biopolymers | 4 | 2024 | 32 | 1.120 |
Why?
| | Cell Survival | 19 | 2018 | 1074 | 1.070 |
Why?
| | Rats | 34 | 2024 | 5482 | 1.060 |
Why?
| | Myofibroblasts | 5 | 2021 | 121 | 1.060 |
Why?
| | Transforming Growth Factor beta3 | 4 | 2021 | 8 | 1.020 |
Why?
| | Infrared Rays | 4 | 2016 | 21 | 1.010 |
Why?
| | Chemokine CXCL12 | 4 | 2021 | 79 | 1.010 |
Why?
| | Bone Morphogenetic Protein 2 | 3 | 2015 | 63 | 1.000 |
Why?
| | NIH 3T3 Cells | 10 | 2018 | 140 | 1.000 |
Why?
| | Endothelial Cells | 7 | 2024 | 746 | 0.980 |
Why?
| | Photochemical Processes | 7 | 2024 | 104 | 0.980 |
Why?
| | Mice | 45 | 2025 | 16915 | 0.980 |
Why?
| | Humans | 136 | 2025 | 129248 | 0.980 |
Why?
| | Porosity | 9 | 2022 | 92 | 0.980 |
Why?
| | Dimethylpolysiloxanes | 2 | 2017 | 10 | 0.970 |
Why?
| | Regenerative Medicine | 6 | 2024 | 45 | 0.940 |
Why?
| | Methacrylates | 8 | 2016 | 112 | 0.930 |
Why?
| | Collagen | 9 | 2025 | 433 | 0.900 |
Why?
| | Interleukin-10 | 5 | 2018 | 300 | 0.860 |
Why?
| | Guided Tissue Regeneration | 6 | 2015 | 12 | 0.860 |
Why?
| | Adamantane | 5 | 2021 | 16 | 0.850 |
Why?
| | Rats, Sprague-Dawley | 18 | 2024 | 2396 | 0.830 |
Why?
| | Elastic Modulus | 12 | 2019 | 122 | 0.830 |
Why?
| | Esters | 4 | 2022 | 73 | 0.830 |
Why?
| | Signal Transduction | 10 | 2023 | 4926 | 0.820 |
Why?
| | Hyaluronan Receptors | 3 | 2019 | 96 | 0.810 |
Why?
| | Nanotechnology | 3 | 2014 | 122 | 0.770 |
Why?
| | Heart Ventricles | 8 | 2022 | 781 | 0.760 |
Why?
| | Endothelial Progenitor Cells | 5 | 2021 | 20 | 0.760 |
Why?
| | Tensile Strength | 13 | 2025 | 93 | 0.750 |
Why?
| | Oligopeptides | 5 | 2019 | 258 | 0.740 |
Why?
| | Stress, Mechanical | 12 | 2025 | 467 | 0.740 |
Why?
| | Neovascularization, Physiologic | 10 | 2019 | 175 | 0.730 |
Why?
| | Decanoates | 3 | 2010 | 4 | 0.720 |
Why?
| | Photochemistry | 11 | 2009 | 132 | 0.720 |
Why?
| | Fractures, Cartilage | 3 | 2015 | 4 | 0.720 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 3 | 2018 | 8 | 0.710 |
Why?
| | Nerve Growth Factors | 4 | 2009 | 73 | 0.680 |
Why?
| | Precision Medicine | 3 | 2023 | 386 | 0.680 |
Why?
| | Cattle | 14 | 2019 | 977 | 0.670 |
Why?
| | Skull | 4 | 2014 | 129 | 0.670 |
Why?
| | Lactic Acid | 8 | 2010 | 298 | 0.660 |
Why?
| | Polyethyleneimine | 2 | 2016 | 18 | 0.660 |
Why?
| | Cell Communication | 3 | 2019 | 300 | 0.660 |
Why?
| | Biology | 1 | 2021 | 84 | 0.660 |
Why?
| | Small Molecule Libraries | 2 | 2011 | 86 | 0.650 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2022 | 221 | 0.640 |
Why?
| | Nanocomposites | 2 | 2009 | 14 | 0.630 |
Why?
| | Biomechanical Phenomena | 16 | 2025 | 757 | 0.630 |
Why?
| | Polyphenols | 1 | 2018 | 18 | 0.610 |
Why?
| | RNAi Therapeutics | 1 | 2018 | 4 | 0.600 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 187 | 0.600 |
Why?
| | Alginates | 3 | 2016 | 46 | 0.590 |
Why?
| | Extracellular Vesicles | 4 | 2022 | 129 | 0.590 |
Why?
| | Peptide Hydrolases | 2 | 2018 | 107 | 0.590 |
Why?
| | Azo Compounds | 1 | 2018 | 26 | 0.580 |
Why?
| | Biodegradation, Environmental | 5 | 2012 | 80 | 0.580 |
Why?
| | Phosphoproteins | 3 | 2017 | 332 | 0.580 |
Why?
| | Fibrinogen | 1 | 2019 | 163 | 0.580 |
Why?
| | Ink | 4 | 2021 | 10 | 0.560 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2017 | 399 | 0.560 |
Why?
| | Musculoskeletal System | 1 | 2018 | 46 | 0.560 |
Why?
| | Caprolactam | 1 | 2017 | 3 | 0.550 |
Why?
| | Cell Nucleus | 3 | 2017 | 586 | 0.540 |
Why?
| | Gels | 3 | 2019 | 81 | 0.530 |
Why?
| | Organoids | 3 | 2022 | 104 | 0.530 |
Why?
| | Transfection | 3 | 2016 | 915 | 0.530 |
Why?
| | Liver Cirrhosis | 2 | 2016 | 279 | 0.530 |
Why?
| | Models, Cardiovascular | 6 | 2017 | 191 | 0.520 |
Why?
| | Fibroblasts | 8 | 2025 | 947 | 0.510 |
Why?
| | Microscopy, Atomic Force | 5 | 2019 | 116 | 0.510 |
Why?
| | Cell Line | 11 | 2023 | 2779 | 0.500 |
Why?
| | Disease Models, Animal | 19 | 2021 | 4057 | 0.500 |
Why?
| | Microscopy, Electron, Scanning | 9 | 2013 | 196 | 0.500 |
Why?
| | Gene Silencing | 1 | 2016 | 190 | 0.500 |
Why?
| | Shear Strength | 2 | 2015 | 67 | 0.500 |
Why?
| | Molecular Imprinting | 2 | 2015 | 4 | 0.490 |
Why?
| | Osteoarthritis | 3 | 2024 | 168 | 0.490 |
Why?
| | Intercellular Signaling Peptides and Proteins | 5 | 2019 | 374 | 0.490 |
Why?
| | Surface Properties | 10 | 2018 | 397 | 0.480 |
Why?
| | Chemotaxis | 2 | 2012 | 129 | 0.480 |
Why?
| | Bone Regeneration | 1 | 2015 | 23 | 0.480 |
Why?
| | Polymethacrylic Acids | 2 | 2013 | 62 | 0.480 |
Why?
| | Acrylic Resins | 3 | 2025 | 44 | 0.480 |
Why?
| | RNA Interference | 1 | 2016 | 450 | 0.470 |
Why?
| | Genetic Therapy | 1 | 2016 | 288 | 0.460 |
Why?
| | Magnetics | 1 | 2014 | 43 | 0.460 |
Why?
| | Maleimides | 1 | 2014 | 21 | 0.450 |
Why?
| | Tibial Meniscus Injuries | 1 | 2015 | 45 | 0.450 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2014 | 15 | 0.450 |
Why?
| | Bone Marrow Cells | 2 | 2012 | 302 | 0.450 |
Why?
| | Microfluidics | 5 | 2017 | 52 | 0.440 |
Why?
| | Skin | 3 | 2024 | 726 | 0.440 |
Why?
| | Biomedical Engineering | 4 | 2021 | 25 | 0.440 |
Why?
| | Compressive Strength | 6 | 2016 | 69 | 0.430 |
Why?
| | Suspensions | 2 | 2025 | 36 | 0.430 |
Why?
| | Finite Element Analysis | 8 | 2018 | 72 | 0.430 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 171 | 0.420 |
Why?
| | Nanostructures | 3 | 2015 | 100 | 0.420 |
Why?
| | Molecular Structure | 6 | 2013 | 478 | 0.420 |
Why?
| | Transcription Factors | 4 | 2021 | 1647 | 0.410 |
Why?
| | Immunosuppressive Agents | 5 | 2004 | 854 | 0.410 |
Why?
| | Rats, Wistar | 7 | 2019 | 441 | 0.410 |
Why?
| | Proteins | 1 | 2019 | 941 | 0.410 |
Why?
| | Time Factors | 17 | 2019 | 6543 | 0.410 |
Why?
| | Hemodynamics | 5 | 2019 | 1090 | 0.410 |
Why?
| | Bone Substitutes | 2 | 2003 | 25 | 0.410 |
Why?
| | Substantia Nigra | 2 | 2024 | 56 | 0.410 |
Why?
| | Extracellular Matrix Proteins | 3 | 2013 | 143 | 0.400 |
Why?
| | Wound Healing | 4 | 2023 | 305 | 0.390 |
Why?
| | Stem Cell Niche | 1 | 2012 | 53 | 0.380 |
Why?
| | Nerve Regeneration | 2 | 2009 | 62 | 0.380 |
Why?
| | Myocardial Contraction | 4 | 2018 | 335 | 0.370 |
Why?
| | Computer Simulation | 8 | 2021 | 939 | 0.370 |
Why?
| | Aorta | 2 | 2011 | 408 | 0.370 |
Why?
| | Calmodulin | 1 | 2011 | 76 | 0.370 |
Why?
| | Chondroitin Sulfates | 2 | 2009 | 35 | 0.370 |
Why?
| | Gold | 4 | 2021 | 118 | 0.350 |
Why?
| | Biophysics | 2 | 2022 | 68 | 0.350 |
Why?
| | Mice, Nude | 6 | 2018 | 682 | 0.350 |
Why?
| | Polyesters | 8 | 2009 | 71 | 0.350 |
Why?
| | Hypertrophy | 1 | 2011 | 121 | 0.340 |
Why?
| | Myocytes, Cardiac | 5 | 2021 | 499 | 0.340 |
Why?
| | Male | 43 | 2019 | 63501 | 0.340 |
Why?
| | Sheep | 7 | 2023 | 838 | 0.340 |
Why?
| | Immunotherapy | 2 | 2015 | 592 | 0.330 |
Why?
| | Hexuronic Acids | 3 | 2016 | 23 | 0.330 |
Why?
| | Membranes, Artificial | 1 | 2010 | 70 | 0.330 |
Why?
| | Glucuronic Acid | 3 | 2016 | 25 | 0.330 |
Why?
| | Kidney Diseases | 2 | 2013 | 382 | 0.330 |
Why?
| | Ultraviolet Rays | 6 | 2024 | 382 | 0.320 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2019 | 102 | 0.320 |
Why?
| | Biomimetics | 4 | 2021 | 42 | 0.310 |
Why?
| | Gelatin | 3 | 2021 | 42 | 0.310 |
Why?
| | Cell- and Tissue-Based Therapy | 3 | 2016 | 76 | 0.310 |
Why?
| | Axons | 3 | 2024 | 191 | 0.300 |
Why?
| | Ear Auricle | 1 | 2008 | 11 | 0.300 |
Why?
| | Inflammation | 4 | 2016 | 2737 | 0.290 |
Why?
| | Bioprosthesis | 1 | 2008 | 40 | 0.290 |
Why?
| | Transplantation | 1 | 2008 | 31 | 0.290 |
Why?
| | Myocardial Ischemia | 3 | 2015 | 258 | 0.290 |
Why?
| | Implants, Experimental | 3 | 2013 | 19 | 0.280 |
Why?
| | Doxorubicin | 1 | 2009 | 328 | 0.280 |
Why?
| | Neurogenesis | 1 | 2009 | 124 | 0.280 |
Why?
| | Molecular Weight | 4 | 2009 | 328 | 0.280 |
Why?
| | Bioengineering | 2 | 2019 | 19 | 0.270 |
Why?
| | Focal Adhesions | 3 | 2018 | 44 | 0.270 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2018 | 37 | 0.270 |
Why?
| | Mitral Valve Insufficiency | 2 | 2019 | 67 | 0.270 |
Why?
| | Ear Cartilage | 1 | 2006 | 3 | 0.270 |
Why?
| | Waiting Lists | 3 | 2008 | 237 | 0.270 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2018 | 113 | 0.270 |
Why?
| | Anisotropy | 7 | 2025 | 73 | 0.270 |
Why?
| | Lymphocytes | 2 | 1999 | 378 | 0.260 |
Why?
| | Electrochemistry | 4 | 2011 | 80 | 0.260 |
Why?
| | Prostheses and Implants | 3 | 2019 | 130 | 0.260 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 901 | 0.260 |
Why?
| | Norbornanes | 3 | 2024 | 15 | 0.260 |
Why?
| | Cell Proliferation | 10 | 2019 | 2374 | 0.260 |
Why?
| | Collagenases | 2 | 2017 | 23 | 0.260 |
Why?
| | Viscosity | 3 | 2018 | 90 | 0.260 |
Why?
| | Glioblastoma | 2 | 2021 | 322 | 0.260 |
Why?
| | Heart | 3 | 2016 | 637 | 0.250 |
Why?
| | Kinetics | 5 | 2021 | 1644 | 0.250 |
Why?
| | Cell Enlargement | 1 | 2005 | 5 | 0.250 |
Why?
| | Growth Substances | 2 | 2003 | 150 | 0.250 |
Why?
| | Drug Compounding | 5 | 2018 | 97 | 0.250 |
Why?
| | Diastole | 2 | 2016 | 148 | 0.240 |
Why?
| | Neurites | 1 | 2005 | 45 | 0.240 |
Why?
| | Temperature | 4 | 2011 | 634 | 0.240 |
Why?
| | Durapatite | 3 | 2014 | 34 | 0.230 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 106 | 0.230 |
Why?
| | 3T3 Cells | 3 | 2018 | 153 | 0.230 |
Why?
| | Biomedical Research | 1 | 2011 | 637 | 0.230 |
Why?
| | Cells, Immobilized | 3 | 2016 | 21 | 0.230 |
Why?
| | Flow Cytometry | 3 | 2019 | 1155 | 0.230 |
Why?
| | Calcification, Physiologic | 2 | 2013 | 33 | 0.230 |
Why?
| | Recovery of Function | 7 | 2019 | 641 | 0.220 |
Why?
| | Magnetic Resonance Imaging | 8 | 2016 | 3386 | 0.220 |
Why?
| | Emulsions | 2 | 2022 | 51 | 0.220 |
Why?
| | Bone Marrow Transplantation | 2 | 2018 | 275 | 0.220 |
Why?
| | Elasticity | 4 | 2010 | 194 | 0.220 |
Why?
| | Dopaminergic Neurons | 1 | 2024 | 57 | 0.220 |
Why?
| | Goats | 1 | 2023 | 26 | 0.220 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 3 | 2015 | 184 | 0.220 |
Why?
| | Azetidines | 1 | 2024 | 40 | 0.220 |
Why?
| | Orthopedics | 2 | 2023 | 135 | 0.220 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2022 | 77 | 0.210 |
Why?
| | Immunohistochemistry | 5 | 2014 | 1691 | 0.210 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2023 | 22 | 0.210 |
Why?
| | Proteolysis | 2 | 2015 | 167 | 0.210 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 33 | 0.210 |
Why?
| | Intervertebral Disc | 1 | 2023 | 39 | 0.210 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 110 | 0.210 |
Why?
| | Corpus Striatum | 1 | 2024 | 159 | 0.200 |
Why?
| | Glass | 2 | 2016 | 43 | 0.200 |
Why?
| | Butadienes | 1 | 2003 | 36 | 0.200 |
Why?
| | Purines | 1 | 2024 | 172 | 0.200 |
Why?
| | Cues | 2 | 2022 | 325 | 0.200 |
Why?
| | Technology | 1 | 2023 | 87 | 0.200 |
Why?
| | Alkaline Phosphatase | 4 | 2013 | 146 | 0.200 |
Why?
| | Recombinant Proteins | 3 | 2018 | 1304 | 0.190 |
Why?
| | Polyhydroxyethyl Methacrylate | 2 | 2013 | 10 | 0.190 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2012 | 49 | 0.190 |
Why?
| | Hydrazones | 1 | 2022 | 26 | 0.190 |
Why?
| | Mice, Inbred BALB C | 4 | 2015 | 1247 | 0.190 |
Why?
| | Hydrazines | 1 | 2022 | 34 | 0.190 |
Why?
| | Thermodynamics | 3 | 2021 | 406 | 0.190 |
Why?
| | Pentoxifylline | 2 | 1999 | 24 | 0.190 |
Why?
| | Baths | 1 | 2021 | 15 | 0.190 |
Why?
| | Models, Biological | 4 | 2018 | 1722 | 0.190 |
Why?
| | Biliary Atresia | 1 | 2023 | 161 | 0.190 |
Why?
| | Neostriatum | 1 | 2021 | 34 | 0.180 |
Why?
| | Aldehydes | 1 | 2022 | 142 | 0.180 |
Why?
| | Green Fluorescent Proteins | 3 | 2018 | 385 | 0.180 |
Why?
| | Nerve Fibers | 1 | 2021 | 89 | 0.180 |
Why?
| | Models, Animal | 4 | 2021 | 376 | 0.180 |
Why?
| | Drug Implants | 2 | 2015 | 82 | 0.180 |
Why?
| | Drug Liberation | 2 | 2018 | 30 | 0.180 |
Why?
| | Aggrecans | 2 | 2011 | 14 | 0.180 |
Why?
| | Collagen Type II | 2 | 2011 | 48 | 0.170 |
Why?
| | Cyclodextrins | 2 | 2021 | 7 | 0.170 |
Why?
| | Pyrazoles | 1 | 2024 | 404 | 0.170 |
Why?
| | Apoptosis | 2 | 2013 | 2498 | 0.170 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2835 | 0.170 |
Why?
| | Metal Nanoparticles | 1 | 2021 | 81 | 0.170 |
Why?
| | Polysaccharides | 1 | 2020 | 86 | 0.170 |
Why?
| | Chickens | 2 | 2011 | 189 | 0.170 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 171 | 0.170 |
Why?
| | Fibrosis | 6 | 2020 | 520 | 0.170 |
Why?
| | Cartilage Diseases | 1 | 2020 | 39 | 0.170 |
Why?
| | Sulfonamides | 1 | 2024 | 495 | 0.170 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 295 | 0.170 |
Why?
| | Collagen Type I | 2 | 2011 | 118 | 0.170 |
Why?
| | Disease | 1 | 2021 | 95 | 0.170 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 77 | 0.170 |
Why?
| | In Vitro Techniques | 3 | 2015 | 1085 | 0.170 |
Why?
| | Acrylates | 2 | 2011 | 45 | 0.160 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 398 | 0.160 |
Why?
| | Macrophages | 3 | 2014 | 1484 | 0.160 |
Why?
| | Acyltransferases | 2 | 2017 | 55 | 0.160 |
Why?
| | Pyrrolidinones | 1 | 1999 | 29 | 0.160 |
Why?
| | Mitral Valve | 1 | 2019 | 85 | 0.160 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 89 | 0.160 |
Why?
| | Terminology as Topic | 2 | 2017 | 203 | 0.160 |
Why?
| | Gene Expression Regulation | 4 | 2013 | 2537 | 0.160 |
Why?
| | Anhydrides | 3 | 2005 | 18 | 0.150 |
Why?
| | Chromatin | 1 | 2022 | 478 | 0.150 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 145 | 0.150 |
Why?
| | Matrix Metalloproteinases | 2 | 2022 | 90 | 0.150 |
Why?
| | Swine, Miniature | 2 | 2015 | 81 | 0.150 |
Why?
| | Angiogenic Proteins | 1 | 2018 | 16 | 0.150 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2018 | 54 | 0.150 |
Why?
| | Dextran Sulfate | 1 | 2018 | 78 | 0.150 |
Why?
| | Drug Synergism | 2 | 2015 | 370 | 0.150 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2018 | 77 | 0.150 |
Why?
| | Polyglycolic Acid | 4 | 2010 | 39 | 0.150 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 400 | 0.150 |
Why?
| | Isomerism | 1 | 2018 | 53 | 0.150 |
Why?
| | Cell Shape | 2 | 2016 | 54 | 0.150 |
Why?
| | Connective Tissue Cells | 1 | 2017 | 2 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 2008 | 0.140 |
Why?
| | Bioreactors | 2 | 2009 | 42 | 0.140 |
Why?
| | Prions | 1 | 2018 | 46 | 0.140 |
Why?
| | Tacrolimus | 4 | 2004 | 193 | 0.140 |
Why?
| | Serum Albumin, Bovine | 1 | 2018 | 63 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2009 | 537 | 0.140 |
Why?
| | Stromal Cells | 1 | 2018 | 105 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 179 | 0.140 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2017 | 89 | 0.140 |
Why?
| | Spectrophotometry, Ultraviolet | 3 | 2009 | 84 | 0.140 |
Why?
| | Treatment Outcome | 7 | 2015 | 10199 | 0.140 |
Why?
| | Molecular Probes | 1 | 2017 | 37 | 0.140 |
Why?
| | Rats, Nude | 1 | 2017 | 27 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2018 | 68 | 0.140 |
Why?
| | Blood Platelets | 1 | 2020 | 380 | 0.140 |
Why?
| | Adenocarcinoma | 2 | 2023 | 898 | 0.140 |
Why?
| | Photolysis | 2 | 2025 | 90 | 0.140 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2056 | 0.140 |
Why?
| | Cyclosporine | 5 | 2004 | 263 | 0.130 |
Why?
| | Kidney Transplantation | 6 | 2000 | 671 | 0.130 |
Why?
| | Excitation Contraction Coupling | 1 | 2016 | 17 | 0.130 |
Why?
| | Pericardium | 1 | 2017 | 54 | 0.130 |
Why?
| | Cardiovascular Agents | 1 | 2018 | 156 | 0.130 |
Why?
| | Cell Aggregation | 1 | 2016 | 23 | 0.130 |
Why?
| | Cardiac Volume | 2 | 2017 | 12 | 0.130 |
Why?
| | Embryonic Stem Cells | 2 | 2007 | 114 | 0.130 |
Why?
| | Hardness | 1 | 2016 | 17 | 0.130 |
Why?
| | Remission, Spontaneous | 1 | 2016 | 37 | 0.130 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 217 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 616 | 0.130 |
Why?
| | Neurotrophin 3 | 2 | 2006 | 9 | 0.130 |
Why?
| | Bioartificial Organs | 1 | 2016 | 3 | 0.130 |
Why?
| | Heart Conduction System | 1 | 2016 | 95 | 0.130 |
Why?
| | Adhesiveness | 2 | 2013 | 19 | 0.130 |
Why?
| | Calixarenes | 1 | 2015 | 5 | 0.130 |
Why?
| | Bridged-Ring Compounds | 1 | 2015 | 12 | 0.130 |
Why?
| | Dermis | 1 | 2015 | 31 | 0.120 |
Why?
| | Fibrin | 1 | 2016 | 68 | 0.120 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 161 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2021 | 461 | 0.120 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2015 | 51 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 572 | 0.120 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1933 | 0.120 |
Why?
| | Enzyme Therapy | 1 | 2015 | 4 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 182 | 0.120 |
Why?
| | Nanoparticles | 2 | 2010 | 375 | 0.120 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 131 | 0.120 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2015 | 11 | 0.120 |
Why?
| | Radiography | 2 | 2014 | 794 | 0.120 |
Why?
| | Blood Vessel Prosthesis | 2 | 2013 | 123 | 0.120 |
Why?
| | Phenols | 1 | 2015 | 96 | 0.120 |
Why?
| | Glycosaminoglycans | 2 | 2012 | 84 | 0.110 |
Why?
| | Ventricular Function | 1 | 2014 | 61 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 387 | 0.110 |
Why?
| | Weight-Bearing | 2 | 2013 | 162 | 0.110 |
Why?
| | DNA | 3 | 2009 | 1396 | 0.110 |
Why?
| | Menisci, Tibial | 1 | 2015 | 59 | 0.110 |
Why?
| | Fracture Healing | 1 | 2014 | 75 | 0.110 |
Why?
| | Immune Tolerance | 1 | 2017 | 355 | 0.110 |
Why?
| | Technology, Pharmaceutical | 1 | 2014 | 20 | 0.110 |
Why?
| | Imidazoles | 1 | 2015 | 234 | 0.110 |
Why?
| | Lung | 3 | 2023 | 3926 | 0.110 |
Why?
| | Bone Remodeling | 1 | 2014 | 71 | 0.110 |
Why?
| | Kidney | 4 | 2016 | 1385 | 0.110 |
Why?
| | Cardiomyopathies | 2 | 2017 | 340 | 0.110 |
Why?
| | Injections, Intradermal | 1 | 2013 | 13 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2515 | 0.110 |
Why?
| | Graft Survival | 5 | 2018 | 511 | 0.110 |
Why?
| | Neuregulin-1 | 1 | 2014 | 46 | 0.110 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 107 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 373 | 0.110 |
Why?
| | Neovascularization, Pathologic | 1 | 2016 | 296 | 0.110 |
Why?
| | Solubility | 1 | 2014 | 232 | 0.110 |
Why?
| | Glucocorticoids | 1 | 1998 | 578 | 0.110 |
Why?
| | Prosthesis Design | 1 | 2015 | 306 | 0.110 |
Why?
| | Vinculin | 1 | 2013 | 10 | 0.110 |
Why?
| | Reperfusion Injury | 1 | 2016 | 272 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2013 | 38 | 0.100 |
Why?
| | Osseointegration | 1 | 2013 | 56 | 0.100 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 157 | 0.100 |
Why?
| | Graft Rejection | 5 | 2000 | 598 | 0.100 |
Why?
| | Fibrocartilage | 1 | 2012 | 5 | 0.100 |
Why?
| | Echocardiography | 2 | 2016 | 629 | 0.100 |
Why?
| | Receptors, Notch | 1 | 2013 | 84 | 0.100 |
Why?
| | Coculture Techniques | 3 | 2019 | 223 | 0.100 |
Why?
| | PPAR gamma | 1 | 2013 | 183 | 0.100 |
Why?
| | Biological Products | 1 | 2016 | 200 | 0.100 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 455 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2012 | 530 | 0.100 |
Why?
| | Cardiac Output | 2 | 2011 | 156 | 0.100 |
Why?
| | Static Electricity | 1 | 2012 | 116 | 0.100 |
Why?
| | Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2011 | 2 | 0.100 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 211 | 0.100 |
Why?
| | Methylmethacrylates | 1 | 2011 | 4 | 0.100 |
Why?
| | Transition Temperature | 1 | 2011 | 27 | 0.090 |
Why?
| | P-Selectin | 1 | 2011 | 27 | 0.090 |
Why?
| | Myocardial Reperfusion | 1 | 2011 | 50 | 0.090 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2011 | 24 | 0.090 |
Why?
| | Cell Polarity | 1 | 2012 | 139 | 0.090 |
Why?
| | Acrylamides | 1 | 2011 | 57 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 480 | 0.090 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 81 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 74 | 0.090 |
Why?
| | A Kinase Anchor Proteins | 1 | 2011 | 71 | 0.090 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2011 | 48 | 0.090 |
Why?
| | Protein Engineering | 1 | 2011 | 106 | 0.090 |
Why?
| | Microvessels | 1 | 2011 | 82 | 0.090 |
Why?
| | Polymerization | 1 | 2011 | 123 | 0.090 |
Why?
| | Micelles | 1 | 2010 | 37 | 0.080 |
Why?
| | Models, Chemical | 2 | 2002 | 262 | 0.080 |
Why?
| | Glycolates | 2 | 2010 | 3 | 0.080 |
Why?
| | Cell Division | 2 | 2004 | 796 | 0.080 |
Why?
| | Molecular Conformation | 1 | 2010 | 141 | 0.080 |
Why?
| | Pressure | 1 | 2010 | 237 | 0.080 |
Why?
| | Coronary Vessels | 1 | 2011 | 239 | 0.080 |
Why?
| | Macromolecular Substances | 1 | 2010 | 216 | 0.080 |
Why?
| | Chitosan | 2 | 2007 | 32 | 0.080 |
Why?
| | Microscopy | 1 | 2010 | 141 | 0.080 |
Why?
| | Ethylene Glycols | 1 | 2009 | 15 | 0.080 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 138 | 0.080 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2009 | 14 | 0.080 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2009 | 11 | 0.080 |
Why?
| | Absorption | 1 | 2009 | 57 | 0.080 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2009 | 72 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 566 | 0.080 |
Why?
| | Liposomes | 1 | 2010 | 171 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2003 | 0.080 |
Why?
| | Surface-Active Agents | 1 | 2009 | 84 | 0.080 |
Why?
| | Methylprednisolone | 2 | 1999 | 83 | 0.080 |
Why?
| | Lactates | 2 | 2005 | 85 | 0.080 |
Why?
| | Mesoderm | 1 | 2009 | 137 | 0.080 |
Why?
| | Pyrroles | 1 | 2009 | 202 | 0.080 |
Why?
| | Metals | 1 | 2009 | 123 | 0.070 |
Why?
| | Peripheral Nerves | 1 | 2009 | 69 | 0.070 |
Why?
| | Adult | 11 | 2021 | 35495 | 0.070 |
Why?
| | Sheep, Domestic | 2 | 2019 | 34 | 0.070 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2008 | 8 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 820 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3201 | 0.070 |
Why?
| | Asia | 1 | 2008 | 58 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2016 | 790 | 0.070 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 305 | 0.070 |
Why?
| | Propylene Glycols | 1 | 2007 | 27 | 0.070 |
Why?
| | Hydrolysis | 1 | 2008 | 186 | 0.070 |
Why?
| | Immunoenzyme Techniques | 1 | 2008 | 214 | 0.070 |
Why?
| | Organ Specificity | 1 | 2008 | 295 | 0.070 |
Why?
| | Equipment Design | 1 | 2009 | 513 | 0.070 |
Why?
| | Geography | 1 | 2008 | 186 | 0.070 |
Why?
| | Travel | 1 | 2008 | 121 | 0.070 |
Why?
| | Ventricular Pressure | 2 | 2018 | 44 | 0.070 |
Why?
| | Muscle Cells | 1 | 2007 | 42 | 0.070 |
Why?
| | Phenotype | 4 | 2025 | 3074 | 0.070 |
Why?
| | Neurons | 3 | 2021 | 1494 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2013 | 1117 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2016 | 152 | 0.070 |
Why?
| | Ligands | 2 | 2021 | 621 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 271 | 0.070 |
Why?
| | Cell Count | 3 | 2013 | 311 | 0.060 |
Why?
| | Hot Temperature | 1 | 2009 | 369 | 0.060 |
Why?
| | Lipids | 1 | 2010 | 625 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 545 | 0.060 |
Why?
| | Tissue and Organ Procurement | 2 | 2008 | 288 | 0.060 |
Why?
| | Adipates | 1 | 2005 | 2 | 0.060 |
Why?
| | Decanoic Acids | 1 | 2005 | 8 | 0.060 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 2005 | 8 | 0.060 |
Why?
| | Ethylamines | 1 | 2005 | 5 | 0.060 |
Why?
| | Erythroblasts | 1 | 2005 | 15 | 0.060 |
Why?
| | Muscles | 2 | 2001 | 321 | 0.060 |
Why?
| | Cohort Studies | 2 | 2010 | 5408 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2014 | 834 | 0.060 |
Why?
| | Cardiac Surgical Procedures | 1 | 2010 | 499 | 0.060 |
Why?
| | Polyanhydrides | 1 | 2005 | 2 | 0.060 |
Why?
| | Carbohydrate Sequence | 1 | 2005 | 24 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2018 | 696 | 0.060 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 110 | 0.060 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2024 | 36 | 0.060 |
Why?
| | Nucleus Pulposus | 1 | 2023 | 1 | 0.060 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 25 | 0.050 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 163 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2117 | 0.050 |
Why?
| | Transcriptome | 2 | 2021 | 874 | 0.050 |
Why?
| | Bilirubin | 1 | 2023 | 96 | 0.050 |
Why?
| | Myoblasts | 1 | 2023 | 81 | 0.050 |
Why?
| | Retina | 1 | 2005 | 277 | 0.050 |
Why?
| | Cell Separation | 1 | 2004 | 316 | 0.050 |
Why?
| | Psoriasis | 1 | 2024 | 87 | 0.050 |
Why?
| | Tissue Donors | 2 | 1997 | 391 | 0.050 |
Why?
| | Spinal Cord Injuries | 1 | 2006 | 194 | 0.050 |
Why?
| | Chromatography, Gel | 1 | 2003 | 126 | 0.050 |
Why?
| | Biosensing Techniques | 1 | 2004 | 118 | 0.050 |
Why?
| | Perfusion | 1 | 2023 | 197 | 0.050 |
Why?
| | Connective Tissue | 1 | 2022 | 37 | 0.050 |
Why?
| | Rabbits | 1 | 2023 | 777 | 0.050 |
Why?
| | Theranostic Nanomedicine | 1 | 2022 | 12 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 191 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 266 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 22 | 0.050 |
Why?
| | Liver Transplantation | 3 | 1995 | 831 | 0.050 |
Why?
| | Tendons | 1 | 2023 | 106 | 0.050 |
Why?
| | Dopamine | 1 | 2024 | 287 | 0.050 |
Why?
| | Cholic Acid | 1 | 2021 | 5 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 543 | 0.050 |
Why?
| | Aspergillus fumigatus | 1 | 2001 | 23 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 584 | 0.050 |
Why?
| | Photochemotherapy | 1 | 2001 | 32 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 183 | 0.050 |
Why?
| | Chlorobenzenes | 1 | 2001 | 9 | 0.050 |
Why?
| | Succinimides | 1 | 2001 | 17 | 0.040 |
Why?
| | Fluorescent Dyes | 2 | 2015 | 312 | 0.040 |
Why?
| | Contrast Media | 1 | 2023 | 393 | 0.040 |
Why?
| | Nuclear Envelope | 1 | 2021 | 28 | 0.040 |
Why?
| | Polystyrenes | 1 | 2001 | 37 | 0.040 |
Why?
| | Optical Imaging | 1 | 2021 | 56 | 0.040 |
Why?
| | Plasmapheresis | 1 | 2000 | 23 | 0.040 |
Why?
| | Cell Engineering | 1 | 2020 | 9 | 0.040 |
Why?
| | Adsorption | 1 | 2001 | 139 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2020 | 83 | 0.040 |
Why?
| | Kidney Glomerulus | 2 | 1998 | 109 | 0.040 |
Why?
| | Epigenomics | 1 | 2021 | 110 | 0.040 |
Why?
| | Cryopreservation | 1 | 2021 | 92 | 0.040 |
Why?
| | Registries | 1 | 2008 | 1895 | 0.040 |
Why?
| | Fibronectins | 1 | 2020 | 123 | 0.040 |
Why?
| | Rolipram | 1 | 1999 | 3 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2004 | 1109 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 631 | 0.040 |
Why?
| | Tritium | 1 | 1999 | 75 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2000 | 130 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 504 | 0.040 |
Why?
| | Thymidine | 1 | 1999 | 59 | 0.040 |
Why?
| | Neural Pathways | 1 | 2021 | 302 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 217 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 5439 | 0.040 |
Why?
| | Nephrectomy | 1 | 2000 | 160 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 770 | 0.040 |
Why?
| | Cathelicidins | 1 | 2018 | 37 | 0.040 |
Why?
| | Biopsy | 3 | 2016 | 1091 | 0.040 |
Why?
| | beta Karyopherins | 1 | 2018 | 7 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 275 | 0.040 |
Why?
| | RNA-Binding Protein EWS | 1 | 2018 | 24 | 0.040 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2019 | 235 | 0.040 |
Why?
| | Middle Aged | 8 | 2018 | 31087 | 0.040 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 1998 | 43 | 0.040 |
Why?
| | Karyopherins | 1 | 2018 | 19 | 0.040 |
Why?
| | Prednisolone | 1 | 1998 | 82 | 0.040 |
Why?
| | Paracrine Communication | 1 | 2018 | 61 | 0.040 |
Why?
| | Cell Size | 1 | 2018 | 87 | 0.040 |
Why?
| | Living Donors | 1 | 2000 | 286 | 0.040 |
Why?
| | Systole | 1 | 2018 | 191 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2018 | 143 | 0.040 |
Why?
| | Biological Transport, Active | 1 | 2017 | 78 | 0.030 |
Why?
| | Stress Fibers | 1 | 2017 | 18 | 0.030 |
Why?
| | Integrins | 1 | 2018 | 94 | 0.030 |
Why?
| | Cytoplasm | 1 | 2018 | 265 | 0.030 |
Why?
| | Actomyosin | 1 | 2017 | 17 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 64 | 0.030 |
Why?
| | Female | 11 | 2024 | 68543 | 0.030 |
Why?
| | Histones | 1 | 2022 | 588 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 742 | 0.030 |
Why?
| | Health Care Rationing | 1 | 1997 | 57 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 253 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2018 | 182 | 0.030 |
Why?
| | Aged | 4 | 2018 | 22032 | 0.030 |
Why?
| | HeLa Cells | 1 | 2018 | 611 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 112 | 0.030 |
Why?
| | Sus scrofa | 1 | 2016 | 46 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 210 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 505 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1999 | 772 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 230 | 0.030 |
Why?
| | Laparoscopy | 1 | 2000 | 449 | 0.030 |
Why?
| | Acidosis, Renal Tubular | 1 | 1995 | 5 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2016 | 75 | 0.030 |
Why?
| | Oxazines | 1 | 2015 | 27 | 0.030 |
Why?
| | Capsules | 1 | 2015 | 40 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 958 | 0.030 |
Why?
| | Databases, Factual | 1 | 2001 | 1266 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2015 | 166 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1998 | 1288 | 0.030 |
Why?
| | Dextrans | 1 | 2015 | 83 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2014 | 33 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 155 | 0.030 |
Why?
| | Trans-Activators | 1 | 2017 | 388 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 108 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 265 | 0.030 |
Why?
| | Kidney Tubules, Proximal | 1 | 1995 | 125 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 442 | 0.030 |
Why?
| | Homeostasis | 1 | 2018 | 605 | 0.030 |
Why?
| | Venous Cutdown | 1 | 1994 | 1 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 506 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2015 | 541 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2013 | 27 | 0.030 |
Why?
| | Jagged-1 Protein | 1 | 2013 | 23 | 0.030 |
Why?
| | Catheters, Indwelling | 1 | 1994 | 80 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2013 | 10 | 0.030 |
Why?
| | Random Allocation | 1 | 2014 | 346 | 0.030 |
Why?
| | Stroke Volume | 1 | 2016 | 592 | 0.030 |
Why?
| | Attitude to Health | 1 | 1997 | 430 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 90 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2016 | 518 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.020 |
Why?
| | Lactones | 1 | 2012 | 55 | 0.020 |
Why?
| | Creatinine | 3 | 2000 | 491 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2016 | 720 | 0.020 |
Why?
| | L-Selectin | 1 | 2011 | 25 | 0.020 |
Why?
| | Diffusion | 1 | 2012 | 116 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1416 | 0.020 |
Why?
| | Blood Pressure | 2 | 2016 | 1736 | 0.020 |
Why?
| | Fluorescence | 1 | 2012 | 155 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 235 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1688 | 0.020 |
Why?
| | Cyclosporins | 1 | 1991 | 77 | 0.020 |
Why?
| | United States | 1 | 2008 | 13828 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2011 | 138 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2011 | 211 | 0.020 |
Why?
| | Hepatitis B | 1 | 1991 | 63 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1446 | 0.020 |
Why?
| | Surgical Mesh | 1 | 2010 | 46 | 0.020 |
Why?
| | Postoperative Complications | 2 | 2000 | 2473 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 3966 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2011 | 310 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2630 | 0.020 |
Why?
| | Morphogenesis | 1 | 2011 | 158 | 0.020 |
Why?
| | Electric Conductivity | 1 | 2009 | 94 | 0.020 |
Why?
| | Fluorescein | 1 | 2009 | 24 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2009 | 56 | 0.020 |
Why?
| | Sepharose | 1 | 2009 | 33 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 265 | 0.020 |
Why?
| | Histocompatibility Testing | 2 | 2000 | 120 | 0.020 |
Why?
| | Fetal Blood | 1 | 2011 | 317 | 0.020 |
Why?
| | Biological Assay | 1 | 2009 | 118 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2011 | 385 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2011 | 381 | 0.020 |
Why?
| | Pregnancy Complications, Infectious | 1 | 1991 | 367 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 819 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3710 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 160 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 30 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2006 | 92 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2007 | 157 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 91 | 0.020 |
Why?
| | Hypertension | 1 | 1995 | 1242 | 0.020 |
Why?
| | Child | 2 | 2023 | 20773 | 0.020 |
Why?
| | Acute Disease | 2 | 2000 | 978 | 0.020 |
Why?
| | Neuroglia | 1 | 2006 | 163 | 0.010 |
Why?
| | Actins | 1 | 2007 | 411 | 0.010 |
Why?
| | Body Fluids | 1 | 2005 | 63 | 0.010 |
Why?
| | Laminin | 1 | 2004 | 69 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2004 | 213 | 0.010 |
Why?
| | Spinal Cord | 1 | 2006 | 353 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2004 | 224 | 0.010 |
Why?
| | Particle Size | 1 | 2005 | 352 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3079 | 0.010 |
Why?
| | Motor Activity | 1 | 2006 | 675 | 0.010 |
Why?
| | Sequence Tagged Sites | 1 | 2001 | 4 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2001 | 17 | 0.010 |
Why?
| | Information Services | 1 | 2001 | 47 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 692 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2000 | 184 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 525 | 0.010 |
Why?
| | Antibody Formation | 1 | 2000 | 291 | 0.010 |
Why?
| | Antibodies | 1 | 2000 | 398 | 0.010 |
Why?
| | Cytokines | 1 | 2006 | 2013 | 0.010 |
Why?
| | Follow-Up Studies | 2 | 1998 | 4886 | 0.010 |
Why?
| | Bone and Bones | 1 | 2000 | 295 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1269 | 0.010 |
Why?
| | Thrombosis | 1 | 2000 | 343 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 173 | 0.010 |
Why?
| | Internet | 1 | 2001 | 615 | 0.010 |
Why?
| | Lymphoproliferative Disorders | 1 | 1996 | 54 | 0.010 |
Why?
| | Telephone | 1 | 1997 | 167 | 0.010 |
Why?
| | Drug Resistance | 1 | 1996 | 166 | 0.010 |
Why?
| | Diarrhea, Infantile | 1 | 1995 | 8 | 0.010 |
Why?
| | Cadaver | 1 | 1997 | 306 | 0.010 |
Why?
| | Blood Urea Nitrogen | 1 | 1995 | 53 | 0.010 |
Why?
| | Bicarbonates | 1 | 1995 | 42 | 0.010 |
Why?
| | Reperfusion | 1 | 1995 | 38 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 1996 | 189 | 0.010 |
Why?
| | Atrophy | 1 | 1995 | 171 | 0.010 |
Why?
| | Fluid Therapy | 1 | 1995 | 133 | 0.010 |
Why?
| | Oxygenators | 1 | 1994 | 4 | 0.010 |
Why?
| | Axillary Vein | 1 | 1994 | 4 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1994 | 14 | 0.010 |
Why?
| | Subclavian Vein | 1 | 1994 | 15 | 0.010 |
Why?
| | Kidney Tubules | 1 | 1995 | 114 | 0.010 |
Why?
| | Hepatic Artery | 1 | 1994 | 59 | 0.010 |
Why?
| | Interviews as Topic | 1 | 1997 | 704 | 0.010 |
Why?
| | Triazines | 1 | 1974 | 38 | 0.010 |
Why?
| | Jugular Veins | 1 | 1994 | 40 | 0.010 |
Why?
| | Femoral Vein | 1 | 1994 | 32 | 0.010 |
Why?
| | Veins | 1 | 1994 | 60 | 0.010 |
Why?
| | Elbow | 1 | 1994 | 55 | 0.010 |
Why?
| | Incidence | 1 | 2000 | 2636 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1994 | 68 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 662 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 785 | 0.010 |
Why?
| | Portal Vein | 1 | 1994 | 108 | 0.010 |
Why?
| | Catheterization, Central Venous | 1 | 1994 | 103 | 0.010 |
Why?
| | Health Status | 1 | 1997 | 754 | 0.010 |
Why?
| | Blood Transfusion | 1 | 1994 | 295 | 0.010 |
Why?
| | Transplantation, Isogeneic | 1 | 1991 | 17 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1991 | 50 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1991 | 41 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 1991 | 59 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 1991 | 111 | 0.010 |
Why?
| | Hindlimb | 1 | 1991 | 122 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2000 | 14455 | 0.010 |
Why?
| | Major Histocompatibility Complex | 1 | 1991 | 230 | 0.010 |
Why?
| | Heart Rate | 1 | 1994 | 802 | 0.010 |
Why?
| | Kidney Neoplasms | 1 | 1974 | 348 | 0.010 |
Why?
| | Anesthesia | 1 | 1991 | 134 | 0.000 |
Why?
| | Prevalence | 1 | 1995 | 2554 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1995 | 2716 | 0.000 |
Why?
| | Risk Factors | 1 | 2000 | 9745 | 0.000 |
Why?
| | Quality of Life | 1 | 1997 | 2685 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1974 | 2053 | 0.000 |
Why?
| | Infant | 1 | 1995 | 8975 | 0.000 |
Why?
| | Adolescent | 1 | 1998 | 20303 | 0.000 |
Why?
| | Pregnancy | 1 | 1991 | 6391 | 0.000 |
Why?
| | Dimethylamines | 1 | 1974 | 4 | 0.000 |
Why?
| | Neoplasm Transplantation | 1 | 1974 | 256 | 0.000 |
Why?
| | Transplantation, Homologous | 1 | 1974 | 400 | 0.000 |
Why?
|
|
Burdick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|